Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:17:47.983Z.
Calculation as of: 2026-10-06T21:17:47.983Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4ee4545eb4fe5103374f291c717036760539f0ddea1c9b76c24efb1a2679ece0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Odyssey Therapeutics, Inc.
Market Cap
$870.81M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$857.16M
Free Cash Flow Yield
N/A
TTM Avg
2.73%
3Y Avg
5.44%
5Y Avg
9.24%
Market Cap
$884.97M
Free Cash Flow Yield
N/A
TTM Avg
16.58%
3Y Avg
25.91%
5Y Avg
25.91%
Market Cap
$887.50M
Free Cash Flow Yield
10.62%
TTM Avg
10.89%
3Y Avg
6.48%
5Y Avg
5.13%
Market Cap
$887.99M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$853.13M
Free Cash Flow Yield
9.31%
TTM Avg
10.90%
3Y Avg
9.26%
5Y Avg
7.66%
Market Cap
$852.35M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Odyssey Therapeutics, Inc. (ODTX) | $870.81M | N/A | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | N/A | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | N/A | 2.73% | 5.44% | 9.24% |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | N/A | 16.58% | 25.91% | 25.91% |
| Alumis Inc. (ALMS)vs › | $855.38M | N/A | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $887.50M | 10.62% | 10.89% | 6.48% | 5.13% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | N/A | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 9.31% | 10.90% | 9.26% | 7.66% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | N/A | 1.33% | 1.33% | 1.33% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
